🧐 ProPicks AI October update is out now! See which stocks made the listPick Stocks with AI

Top Ranked Income Stocks To Buy For December 20th

Published 12/19/2017, 10:35 PM
Updated 07/09/2023, 06:31 AM
EQNR
-

Here are three stocks with buy rank and strong income characteristics for investors to consider today, December 20th:

H&E Equipment Services, Inc. (HEES): This integrated equipment services company has witnessed the Zacks Consensus Estimate for its current year earnings increasing 43.8% over the last 60 days.

H&E Equipment Services, Inc. Price and Consensus

This Zacks Rank #1 (Buy) company has a dividend yield of 2.81%, compared with the industry average of 0.71%. Its five-year average dividend yield is 3.30%.

H&E Equipment Services, Inc. Dividend Yield (TTM)

BCB Bancorp, Inc. (BCBP): This bank holding company has witnessed the Zacks Consensus Estimate for its current year earnings advancing 10.8% over the last 60 days.

BCB Bancorp, Inc. (NJ) Price and Consensus

This Zacks Rank #2 (Buy) company has a dividend yield of 3.84%, compared with the industry average of 1.43%. Its five-year average dividend yield is 4.56%.

BCB Bancorp, Inc. (NJ) Dividend Yield (TTM)

Escalade, Incorporated (ESCA): This sporting goods seller has witnessed the Zacks Consensus Estimate for its current year earnings increasing 2.7% over the last 60 days.

Escalade, Incorporated Price and Consensus

This Zacks Rank #2 (Buy) company has a dividend yield of 3.43%, compared with the industry average of 0.00%. Its five-year average dividend yield is 3.60%.

Escalade, Incorporated Dividend Yield (TTM)

Statoil (OL:STL) ASA (STO): This energy company has witnessed the Zacks Consensus Estimate for its current year earnings increasing 8.8% over the last 60 days.

Statoil ASA Price and Consensus

This Zacks Rank #1 (Strong Buy) company has a dividend yield of 2.68%, compared with the industry average of 2.76%. Its five-year average dividend yield is 4.44%.

Statoil ASA Dividend Yield (TTM)

See the full list of top ranked stocks here.

Find more top income stocks with some of our great premium screens.

5 Medical Stocks to Buy Now

Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.

New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.

Click here to see the 5 stocks >>



Statoil ASA (STO): Free Stock Analysis Report

H&E Equipment Services, Inc. (HEES): Free Stock Analysis Report

Escalade, Incorporated (ESCA): Free Stock Analysis Report

BCB Bancorp, Inc. (NJ) (BCBP): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Loading next article…
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.